ctrl K

Price Alert

Cyclacel Pharmaceuticals ... (CYCC)

NASDAQ: CYCC · Real-Time Price · USD

8.21

-0.68 (-7.65%)

At close: Aug 15, 2025, 1:27 PM

Cyclacel Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.14M	3.38M	18.34M	36.56M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	411K	1.26M	3.46M	1.55M
Receivables	237K	2.93M	4.66M	3.73M
Inventory	n/a	n/a	n/a	577K
Other Current Assets	63K	341K	426K	-498K
Total Current Assets	3.67M	7.44M	24.41M	40.94M
Property-Plant & Equipment	8K	102K	174K	94K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	419K	1.36M	3.64M	1.65M
Total Assets	4.09M	8.8M	28.05M	42.59M
Account Payables	4.6M	3.54M	2.56M	2.12M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	283K	380K	1.01M	753K
Total Current Liabilities	6.27M	8.16M	7.51M	5.41M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	37K	106K	30K
Total Liabilities	6.27M	8.2M	7.62M	5.44M
Total Debt	n/a	37K	106K	30K
Common Stock	9K	1K	4.5M	10K
Retained Earnings	-439.49M	-428.28M	-405.73M	-384.53M
Comprehensive Income	-891K	-908K	-1.32M	-748K
Shareholders Equity	-2.17M	607K	20.43M	37.69M
Total Investments	n/a	n/a	n/a	n/a